Cardiovascular complications in atypical haemolytic uraemic syndrome

作者: Marina Noris , Giuseppe Remuzzi

DOI: 10.1038/NRNEPH.2013.280

关键词:

摘要: Haemolytic uraemic syndrome (HUS) is characterized by nonimmune haemolytic anaemia, thrombocytopenia and renal impairment-most incidents in childhood are caused shiga toxin-producing bacteria. Atypical HUS (aHUS) accounts for 10% of cases has a poor prognosis. About 60% patients with aHUS have dysregulation the alternative complement pathway (complement-mediated aHUS). The kidney main target organ, but other organs might also be affected. Cardiac complications occur 3-10% complement-mediated aHUS, as consequence microangiopathic injury coronary microvasculature, can cause sudden death. Emerging evidence suggests that either thrombosis or stenosis medium large arteries complicate disease course, such disorders even after function lost. In this Perspectives article we discuss impact cardiovascular involvement role acute chronic hyperactivation events implications treatment.

参考文章(72)
Mark J. Walport, Complement. First of two parts. The New England Journal of Medicine. ,vol. 344, pp. 1058- 1066 ,(2001) , 10.1056/NEJM200104053441406
Ahmet Özel, Ümran Çalışkan, Şafak Gücer, Peripheral gangrene complicating hemolytic uremic syndrome in a child. Pediatric Nephrology. ,vol. 18, pp. 465- 467 ,(2003) , 10.1007/S00467-002-0973-4
Eckhard R. Podack, William P. Kolb, Hans J. Müller-Eberhard, The SC5b-7 complex: Formation, isolation, properties, and subunit composition Journal of Immunology. ,vol. 119, pp. 2024- 2029 ,(1977)
Motoshi Sawada, Hiroji Yanamoto, Izumi Nagata, Nobuo Hashimoto, Ichiro Nakahara, Yoshinori Akiyama, Haruhiko Kikuchi, None, Prevention of Neointimal Formation by a Serine Protease Inhibitor, FUT-175, After Carotid Balloon Injury in Rats Stroke. ,vol. 30, pp. 644- 650 ,(1999) , 10.1161/01.STR.30.3.644
Peter J. Lachmann, The amplification loop of the complement pathways. Advances in Immunology. ,vol. 104, pp. 115- 149 ,(2009) , 10.1016/S0065-2776(08)04004-2
Tamara Manuelian, Jens Hellwage, Seppo Meri, Jessica Caprioli, Marina Noris, Stefan Heinen, Mihaly Jozsi, Hartmut PH Neumann, Giuseppe Remuzzi, Peter F Zipfel, None, Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome Journal of Clinical Investigation. ,vol. 111, pp. 1181- 1190 ,(2003) , 10.1172/JCI16651
Paul Warwicker, Timothy H.J. Goodship, Rosemary L. Donne, Yves Pirson, Anthony Nicholls, Roy M. Ward, Peter Turnpenny, Judith A. Goodship, Genetic studies into inherited and sporadic hemolytic uremic syndrome Kidney International. ,vol. 53, pp. 836- 844 ,(1998) , 10.1111/J.1523-1755.1998.00824.X
Aditi Sinha, Ashima Gulati, Savita Saini, Caroline Blanc, Aarti Gupta, Bahadur Singh Gurjar, Himanshi Saini, Shambhuprasad T Kotresh, Uma Ali, Divya Bhatia, Alpana Ohri, Manish Kumar, Indira Agarwal, Sanjeev Gulati, Kanav Anand, M Vijayakumar, Rajiv Sinha, Sidharth Sethi, Maud Salmona, Anna George, Vineeta Bal, Geetika Singh, Amit K Dinda, Pankaj Hari, Satyajit Rath, Marie-Agnes Dragon-Durey, Arvind Bagga, None, Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children Kidney International. ,vol. 85, pp. 1151- 1160 ,(2014) , 10.1038/KI.2013.373
Cynthia Abarrategui-Garrido, Rubén Martínez-Barricarte, Margarita López-Trascasa, Santiago Rodríguez de Córdoba, Pilar Sánchez-Corral, Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood. ,vol. 114, pp. 4261- 4271 ,(2009) , 10.1182/BLOOD-2009-05-223834